Our system is currently under heavy load due to increased usage. We're actively working on upgrades to improve performance. Thank you for your patience.
2022
DOI: 10.1016/bs.mie.2022.07.015
|View full text |Cite
|
Sign up to set email alerts
|

Nanoluciferase-based cell fusion assay for rapid and high-throughput assessment of SARS-CoV-2-neutralizing antibodies in patient samples

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 65 publications
0
1
0
Order By: Relevance
“…This is hydrolyzed at a slow rate by cellular esterases and releases furimazine throughout the experiment. 28 , 29 Incubation with 1 nM TNFα resulted in a large stimulation of HiBiT-E-selectin cell surface expression that began after 2 h and peaked at 8 h ( Figure 7 A). The difference in the peak cell surface expression of HiBiT E-selectin between TNFα (1 nM) and vehicle-treated cells was substantial (p < 0.001; Figure 7 B).…”
Section: Resultsmentioning
confidence: 99%
“…This is hydrolyzed at a slow rate by cellular esterases and releases furimazine throughout the experiment. 28 , 29 Incubation with 1 nM TNFα resulted in a large stimulation of HiBiT-E-selectin cell surface expression that began after 2 h and peaked at 8 h ( Figure 7 A). The difference in the peak cell surface expression of HiBiT E-selectin between TNFα (1 nM) and vehicle-treated cells was substantial (p < 0.001; Figure 7 B).…”
Section: Resultsmentioning
confidence: 99%